900573-88-8,MFCD26142530
Catalog No.:AA00GU12

900573-88-8 | JI-101

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
98+%
in stock  
$40.00   $28.00
- +
10mg
98+%
in stock  
$60.00   $42.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00GU12
Chemical Name:
JI-101
CAS Number:
900573-88-8
Molecular Formula:
C22H20BrN5O2
Molecular Weight:
466.3305
MDL Number:
MFCD26142530
SMILES:
COc1ccc(cc1NC(=O)Nc1cccc2c1ccn2Cc1cc[nH]c(=N)c1)Br
Properties
Computed Properties
 
Complexity:
582  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
30  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0  
Rotatable Bond Count:
5  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.4  

Literature

Title: A strategy for extending the applicability of a validated plasma calibration curve to quantitative measurements in multiple tissue homogenate samples: a case study from a rat tissue distribution study of JI-101, a triple kinase inhibitor.

Journal: Biomedical chromatography : BMC 20120401

Title: Highly sensitive method for the determination of JI-101, a multi-kinase inhibitor in human plasma and urine by LC-MS/MS-ESI: method validation and application to a clinical pharmacokinetic study.

Journal: Biomedical chromatography : BMC 20120201

Title: Pharmacokinetics, tissue distribution and identification of putative metabolites of JI-101 - a novel triple kinase inhibitor in rats.

Journal: Arzneimittel-Forschung 20120101

Title: Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.

Journal: Biomedical chromatography : BMC 20110701

Title: Gurav SD, et al. Pharmacokinetics, tissue distribution and identification of putative metabolites of JI-101 - a novel triple kinase inhibitor in rats. Arzneimittelforschung. 2012 Jan;62(1):27-34.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 900573-88-8
Tags:900573-88-8 Molecular Formula|900573-88-8 MDL|900573-88-8 SMILES|900573-88-8 JI-101
Catalog No.: AA00GU12
900573-88-8,MFCD26142530
900573-88-8 | JI-101
Pack Size: 5mg
Purity: 98+%
in stock
$40.00 $28.00
Pack Size: 10mg
Purity: 98+%
in stock
$60.00 $42.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00GU12
Chemical Name: JI-101
CAS Number: 900573-88-8
Molecular Formula: C22H20BrN5O2
Molecular Weight: 466.3305
MDL Number: MFCD26142530
SMILES: COc1ccc(cc1NC(=O)Nc1cccc2c1ccn2Cc1cc[nH]c(=N)c1)Br
Properties
Complexity: 582  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 30  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 3  
Isotope Atom Count: 0  
Rotatable Bond Count: 5  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.4  
Literature fold

Title: A strategy for extending the applicability of a validated plasma calibration curve to quantitative measurements in multiple tissue homogenate samples: a case study from a rat tissue distribution study of JI-101, a triple kinase inhibitor.

Journal: Biomedical chromatography : BMC20120401

Title: Highly sensitive method for the determination of JI-101, a multi-kinase inhibitor in human plasma and urine by LC-MS/MS-ESI: method validation and application to a clinical pharmacokinetic study.

Journal: Biomedical chromatography : BMC20120201

Title: Pharmacokinetics, tissue distribution and identification of putative metabolites of JI-101 - a novel triple kinase inhibitor in rats.

Journal: Arzneimittel-Forschung20120101

Title: Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.

Journal: Biomedical chromatography : BMC20110701

Title: Gurav SD, et al. Pharmacokinetics, tissue distribution and identification of putative metabolites of JI-101 - a novel triple kinase inhibitor in rats. Arzneimittelforschung. 2012 Jan;62(1):27-34.

Building Blocks More >
938448-87-4
938448-87-4
Bucladesine (calciuM salt)
AA00GU5D | MFCD13152130
923205-85-0
923205-85-0
3-Isopropylisoxazolo[5,4-b]pyridine-5-carboxylic acid
AA00GU9H | MFCD08444501
878125-78-1
878125-78-1
2-CHLORO-N-(THIEN-2-YLMETHYL)PROPANAMIDE
AA00GUCU | MFCD08256162
902742-67-0
902742-67-0
4,6-Dichloro-2-quinolinecarboxylic acid
AA00GUK9 | MFCD06810543
86630-50-4
86630-50-4
methylcyclohexyl piperidine perfluoride
AA00GUR9 | MFCD06411482
889113-64-8
889113-64-8
Boc-alpha-methyl-d-4-fluorophenylalanine
AA00GV21 | MFCD08458687
923010-68-8
923010-68-8
2-Amino-6-(tert-butoxycarbonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylic acid
AA00GVCP | MFCD12031524
940980-96-1
940980-96-1
4-(1-Pyrrolidinyl)-1,3,5-triazin-2-amine
AA00GVI1 | MFCD09864540
874622-79-4
874622-79-4
4-[(Methylamino)carbonyl]benzenesulfonyl chloride
AA00GVLT | MFCD07691322
91790-39-5
91790-39-5
1,7-Dimethyl-1h-indole-2,3-dione
AA00GVQG | MFCD00565658
Submit
© 2017 AA BLOCKS, INC. All rights reserved.